Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amyris Inc AMRSQ

Chemicals Specialty Chemicals
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F... see more

Recent & Breaking News (GREY:AMRSQ)

Technical Reports on Basic Materials Equities -- LyondellBasell Industries, Amyris, Platform Specialty Products, and Ternium

PR Newswire May 10, 2017

Amyris to Host & Videocast 1st Annual Biotech Summit and Investor Day on Tuesday, May 16, 2017

GlobeNewswire May 9, 2017

Amyris to Announce First Quarter 2017 Financial Results on Monday, May 15, 2017

GlobeNewswire May 9, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amyris, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017

Business Wire May 8, 2017

Amyris Announces Agreements For Up to $95 Million In Equity Financing And In-Process Initiative To Significantly Reduce Debt

GlobeNewswire May 8, 2017

Royal DSM To Make Equity Investment In Amyris With the Purpose of Establishing a Long-Term Relationship

GlobeNewswire May 8, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. – AMRS

GlobeNewswire May 5, 2017

Amyris Announces Much Better Than Expected Sales Of Farnesene To Meet Accelerated Demand For Liquid Farnesene Rubber By Global Tire Brands

GlobeNewswire May 5, 2017

The Klein Law Firm Announces a Class Action Filed on Behalf of Amyris, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017

GlobeNewswire May 4, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Amyris, Inc. Investors

Business Wire May 4, 2017

IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

GlobeNewswire May 3, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Citizens Financial Group, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire May 3, 2017

IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm

PR Newswire May 2, 2017

AMRS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Amyris, Inc. and a Lead Plaintiff Deadline of June 19, 2017

GlobeNewswire May 2, 2017

Amyris Announces Key Advancements Under DARPA Multi-Year Technology Investment Agreement – Enables Development of Industrial-Scale Fermentation Process For Virtually Any Biological Molecule

GlobeNewswire May 2, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amyris, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 19, 2017 – AMRS

GlobeNewswire May 1, 2017

Amyris Announces Industrial Production Of Leading Healthy Sweetener Product in 2018

GlobeNewswire May 1, 2017

Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc.

PR Newswire April 28, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm

PR Newswire April 28, 2017

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm

PR Newswire April 27, 2017